🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/12/2013 | 32,18 | 32,76 | 31,32 | 32,52 | +1,09% | 4,48% | 268.342 |
| 17/12/2013 | 32,25 | 32,37 | 31,35 | 32,17 | -0,25% | 3,17% | 287.739 |
| 16/12/2013 | 32,80 | 33,37 | 32,14 | 32,25 | -1,41% | 3,77% | 324.608 |
| 13/12/2013 | 33,04 | 33,04 | 32,13 | 32,71 | -1,11% | 2,78% | 275.716 |
| 12/12/2013 | 32,51 | 33,64 | 32,41 | 33,08 | +1,65% | 3,78% | 409.727 |
| 11/12/2013 | 33,48 | 33,98 | 32,13 | 32,55 | -3,01% | 5,53% | 330.859 |
| 10/12/2013 | 33,43 | 34,37 | 32,99 | 33,56 | -0,11% | 4,11% | 449.962 |
| 09/12/2013 | 33,79 | 34,20 | 33,08 | 33,59 | -0,35% | 3,31% | 320.119 |
| 06/12/2013 | 34,98 | 35,46 | 33,42 | 33,71 | -4,39% | 5,83% | 544.860 |
| 05/12/2013 | 34,43 | 35,55 | 33,87 | 35,26 | +2,52% | 4,86% | 568.264 |
| 04/12/2013 | 35,31 | 35,86 | 33,84 | 34,39 | +2,91% | 5,72% | 603.690 |
| 03/12/2013 | 35,23 | 35,41 | 32,57 | 33,42 | -5,37% | 8,07% | 719.907 |
| 02/12/2013 | 34,68 | 35,81 | 34,31 | 35,32 | +1,67% | 4,32% | 531.875 |
| 29/11/2013 | 35,52 | 35,52 | 34,49 | 34,73 | -2,26% | 2,90% | 436.176 |
| 27/11/2013 | 35,71 | 35,96 | 35,33 | 35,54 | -1,35% | 1,78% | 4.657.837 |
| 26/11/2013 | 35,95 | 36,39 | 35,35 | 36,03 | +5,48% | 2,90% | 1.547.697 |
| 25/11/2013 | 33,54 | 34,45 | 33,54 | 34,15 | +2,26% | 2,72% | 370.614 |
| 22/11/2013 | 32,96 | 34,62 | 32,82 | 33,40 | +2,98% | 5,47% | 544.219 |
| 21/11/2013 | 33,42 | 34,37 | 30,26 | 32,43 | -2,84% | 12,28% | 1.371.367 |
| 20/11/2013 | 32,98 | 33,59 | 31,82 | 33,38 | +1,15% | 5,39% | 441.146 |
| 19/11/2013 | 32,50 | 33,34 | 32,09 | 33,00 | +1,91% | 3,84% | 377.507 |
| 18/11/2013 | 33,36 | 34,03 | 31,94 | 32,38 | -1,20% | 6,27% | 355.065 |
| 15/11/2013 | 31,74 | 33,67 | 30,84 | 32,78 | +7,44% | 8,94% | 910.664 |
| 14/11/2013 | 30,68 | 31,15 | 30,05 | 30,51 | -0,35% | 3,58% | 255.198 |
| 13/11/2013 | 29,94 | 30,64 | 29,63 | 30,61 | +1,36% | 3,37% | 364.202 |
| 12/11/2013 | 30,51 | 30,66 | 29,34 | 30,20 | -1,08% | 4,31% | 315.631 |
| 11/11/2013 | 30,13 | 30,64 | 29,82 | 30,53 | +1,26% | 2,71% | 298.158 |
| 08/11/2013 | 28,35 | 30,56 | 28,23 | 30,15 | +5,89% | 8,23% | 714.297 |
| 07/11/2013 | 30,98 | 31,31 | 28,23 | 28,47 | -6,86% | 9,95% | 727.922 |
| 06/11/2013 | 32,84 | 32,96 | 30,14 | 30,57 | -6,77% | 8,57% | 879.406 |